The Genomic Landscape of TP53 and p53 Annotated High Grade Ovarian Serous Carcinomas from a Defined Founder Population Associated with Patient Outcome

• Paulina M. Wojnarowicz,

  Affiliation Department of Human Genetics, McGill University, Montreal, Quebec, Canada

  ⨯
• Kathleen Klein Oros,

  Affiliation Division of Clinical Epidemiology and Segal Cancer Centre, Lady Davis Research Institute, Jewish General Hospital, Montreal, Quebec, Canada

  ⨯
• Michael C. J. Quinn,

  Affiliation Centre de recherche du Centre hospitalier de l’Université de Montréal (CRCHUM), Institut du Cancer de Montréal, Montreal, Quebec, Canada

  ⨯
• Suzanna L. Arcand,

  Affiliation The Research Institute of the McGill University Health Centre (MUHC), Montreal, Quebec, Canada

  ⨯
• Karen Gambaro,

  Affiliation Department of Human Genetics, McGill University, Montreal, Quebec, Canada

  ⨯
• Jason Madore,

  Affiliation Centre de recherche du Centre hospitalier de l’Université de Montréal (CRCHUM), Institut du Cancer de Montréal, Montreal, Quebec, Canada

  ⨯
• Ashley H. Birch,

  Affiliation Department of Human Genetics, McGill University, Montreal, Quebec, Canada

  ⨯
• Manon de Ladurantaye,

  Affiliation Centre de recherche du Centre hospitalier de l’Université de Montréal (CRCHUM), Institut du Cancer de Montréal, Montreal, Quebec, Canada

  ⨯
• Kurosh Rahimi,

  Affiliation Department of Pathology, Centre Hospitalier de l’Université de Montréal (CHUM), Montreal, Quebec, Canada

  ⨯
• Diane M. Provencher,

  Affiliations Centre de recherche du Centre hospitalier de l’Université de Montréal (CRCHUM), Institut du Cancer de Montréal, Montreal, Quebec, Canada, Division of Gynecologic Oncology, Université de Montréal, Montreal, Quebec, Canada

  ⨯
• Anne-Marie Mes-Masson,

  Affiliations Centre de recherche du Centre hospitalier de l’Université de Montréal (CRCHUM), Institut du Cancer de Montréal, Montreal, Quebec, Canada, Department of Medicine, Université de Montréal, Montreal, Quebec, Canada

  ⨯
• Celia M. T. Greenwood,

  Affiliations Division of Clinical Epidemiology and Segal Cancer Centre, Lady Davis Research Institute, Jewish General Hospital, Montreal, Quebec, Canada, Department of Oncology, McGill University, Montreal, Quebec, Canada, Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, Quebec, Canada

  ⨯
• Patricia N. Tonin

  * E-mail: patricia.tonin@mcgill.ca

  Affiliations Department of Human Genetics, McGill University, Montreal, Quebec, Canada, The Research Institute of the McGill University Health Centre (MUHC), Montreal, Quebec, Canada, Department of Medicine, McGill University, Montreal, Quebec, Canada

  ⨯